scholarly journals Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy

2013 ◽  
Vol 15 (5) ◽  
pp. R146 ◽  
Author(s):  
Cheng Liao ◽  
Jonathan Hsu ◽  
Yong Kim ◽  
Dong-Qing Hu ◽  
Daigen Xu ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document